CHM 10.5% 2.1¢ chimeric therapeutics limited

Ann: Investor Presentation, page-10

  1. 7,814 Posts.
    lightbulb Created with Sketch. 3330
    Does it suggest that the regulators and/or CHM want to assess whether its the delivery method (of bypassing the blood-brain barrier) that is resulting in our impressive data? It's almost like a control arm has been added to the trial design.... to compare CLTX to chemo. I dare say its something to do with our TGA regulations.

    https://hotcopper.com.au/data/attachments/6337/6337178-609632007364164cb0f6cc482f92ffcd.jpg







    Last edited by Shellbell: Yesterday, 19:30
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $30.13K 1.439M

Buyers (Bids)

No. Vol. Price($)
6 623541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 423206 1
View Market Depth
Last trade - 15.53pm 25/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.